News

May 08,2021

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

May 04,2021

Cardea Bio Develops Exosome and Extracellular Vesicles (EV) Detection Technology Called EV-Chip, Showcasing Cancer and Aging Dx Applications

Apr 28,2021

Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer

Mar 30,2021

Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors

Mar 17,2021

Alveo Technologies' be.well COVID-19 Test Wins XPRIZE Rapid Covid Testing Competition

Mar 09,2021

Twist Bioscience Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021

Feb 25,2021

CULLGEN CLOSES $50 MILLION SERIES B INVESTMENT TO ADVANCE TARGETED PROTEIN DEGRADERS AND NOVEL E3 LIGANDS PLATFORM

Jan 13,2021

Cardea Bio Adds $6.5 Million to Series A; Early-Stage Financing Now Totals More Than $20 Million

No more pages to load

Next page